The China Non Alcoholic Steatohepatitis Biomarkers Market is experiencing transformative growth driven by technological advancements, increasing awareness of liver diseases, and evolving regulatory frameworks. The market was valued at USD 7.5 million in 2024 and is projected to reach USD 96.92 million by 2035, exhibiting a CAGR of 26.19% during the forecast period. This growth reflects the...